Free articles: Pharma & healthcate

Page:
  • How will the Reimbursement Act impact the Polish pharma market? April 2012

    The Reimbursement Act, which came into force on 1 January 2012, will have an adverse effect on the growth recorded by both original and generic drugs in Poland, according to our latest report, entitled “Generic and innovative drugs market in Poland 2012. Development forecasts for 2012-2014.” The Reimbursement…
  • Legislative changes to hamper innovative drugs market in Central Europe between 2012 and 2014 April 2012

    Due to legislative changes implemented during 2011 in most of the Central European (CE) countries, the innovative drug market in the region will decline in 2012 by 1%, to €6.1bn at manufacturer prices, according to information contained in our latest report entitled “Generic and innovative drugs market in…
  • Most non-public hospitals in Poland oriented towards public funding February 2012

    The vast majority of non-public hospitals in Poland provide services under contracts with the National Health Fund (NFZ). The number of Poles who can afford to pay for costly hospital procedures out of their own pockets remains small, whereas NFZ contracts guarantee a certain level of revenues and patient numbers. That…
  • The clinical trials market in CIS countries continues to grow February 2012

    Clinical trials in the CIS countries have been developing in a positive fashion (with the exception of Russia, whose development slowed for a while as a result of significant changes in regulations). The expected average growth in value will reach 14% and approximately 13% by volume in the years 2012-2014, according to the…
  • Boom expected on medical equipment market in Poland in 2013 December 2011

    In 2010 the overall Polish medical equipment market grew by 5% year on year. The increase primarily reflected imports, which grew by 6%, to PLN 3.9bn (€1.0bn). According to the most recent PMR report “Medical devices market in Poland 2012. Development forecast for 2012-2014”, the market experienced…
  • Growth forecasts for the Polish market of dietary supplements December 2011

    In 2011-2013, the market of dietary supplements in Poland will develop at a rate of 9-15% annually, according to the latest report published by PMR entitled „Dietary supplements market in Poland 2011. Development forecasts for 2011-2013”. Although the market growth rate is lower than in the preceding year,…
  • OTC market in Central and Eastern Europe expected to grow by 9% per annum between 2011 and 2013 October 2011

    In 2010 OTC product pharmacy sales in Central and Eastern Europe (CEE) were worth €10.7bn, a 13% year on year increase in euro. Between 2011 and 2013 the market should develop by around 9% on average per annum, according to our latest report, entitled “OTC market in Central and Eastern Europe 2011. Comparative…
  • Extensive consolidation confined to the retail industry in Russia October 2011

    In recent years consolidation on the Russian market has taken place mostly in the retail, whereas there has been stagnation on the wholesale market. In Ukraine acquisitions in both wholesale and retail pharmaceutical distribution stopped because of the more cautious policies of companies during the crisis, according to…
  • Non-pharmacy market of OTC products in Poland in 2011-2013 September 2011

    According to our estimates, in 2009 the non-pharmacy market of OTC products (comprising medicines and dietary supplements) rose by around 11% year on year and exceeded PLN 1bn (€231m) for the first time on record. The year 2010 was a period of poorer growth for the pharmaceutical market as a whole, as reflected…
  • Is the development of private healthcare market in Ukraine more rapid than that of Russia? September 2011

    The private healthcare markets in Russia and Ukraine are at the initial stage of development. Informal spending is widespread and this is partially caused by lack of proper payment mechanisms in the system. At the same time the private health insurance segment is immature. According to the latest PMR report, “Private…
Page:

Free e-letters

  • Pharmaceutical overview in Poland, CEE & Russia Pharmaceutical overview in Poland, CEE & Russia Pharmaceutical overview in Poland, CEE & Russia
unsubscribe »